Effects of osteopontin-enriched formula on lymphocyte subsets in the first 6 months of life: a randomized controlled

Christina E West1, Anne Staudt Kvistgaard2, Janet M Peerson3

  • 1Department of Clincial Sciences, Pediatrics, Umeå University, Umeå, Sweden.

Pediatric Research
|March 30, 2017
PubMed

Insights

Osteopontin (OPN) in infant formula, at levels mirroring human milk, boosted T-cell proportions in formula-fed infants. This suggests OPN positively impacts infant immune development in a dose-dependent manner.

Area of Science:

  • * Immunology
  • * Pediatric Nutrition

Background:

  • * Human milk contains osteopontin (OPN), a protein with known immunomodulatory functions.
  • * OPN plays a role in immune system development and regulation.

Purpose of the Study:

  • * To evaluate the effect of varying osteopontin (OPN) concentrations in infant formula on immune cell composition.
  • * To compare formula-fed infants with a breastfed reference group.

Main Methods:

  • * Randomized controlled trial comparing standard formula (SF) with OPN-supplemented formulas (F65, F130).
  • * Four-color immunoflow cytometry used to analyze peripheral blood immune cells at 1, 4, and 6 months.
  • * Comparison with a breastfed (BF) group.

Main Results:

  • * Formula with 130 mg OPN/L (F130) showed increased T-cell proportions versus SF and F65.
  • * Monocyte proportions were higher in OPN-supplemented groups (F65, F130) compared to BF infants.
  • * Effects on T-cells and monocytes appeared dose-dependent.

Conclusions:

  • * OPN in infant formula, at human milk concentrations, increased circulating T-cell proportions.
  • * OPN supplementation may favorably influence immune ontogeny in infancy.
  • * The observed immune effects of OPN are likely dose-dependent.